Cargando…

Editorial: Immune Response to Cerebral Ischemia: Exploring Mechanisms and Potential Treatment Targets

Detalles Bibliográficos
Autores principales:	Ye, YingZe, Gu, Lijuan, Jian, Zhihong, Xiong, Xiaoxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738092/ https://www.ncbi.nlm.nih.gov/pubmed/35003142 http://dx.doi.org/10.3389/fimmu.2021.813836

Ejemplares similares

New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia
por: Chen, Ran, et al.
Publicado: (2021)

Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury
por: Wu, Liquan, et al.
Publicado: (2020)

Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cerebral Ischemia/Reperfusion Injury
por: Wang, Lei, et al.
Publicado: (2022)

NOX2-mediated reactive oxygen species are double-edged swords in focal cerebral ischemia in mice
por: Yingze, Ye, et al.
Publicado: (2022)

The Involvement and Therapy Target of Immune Cells After Ischemic Stroke
por: Jian, Zhihong, et al.
Publicado: (2019)

Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
por: Zhu, Hua, et al.
Publicado: (2021)

Peripheral Organ Injury After Stroke
por: Wang, Jin, et al.
Publicado: (2022)

Adaptive Immunity Regulation and Cerebral Ischemia
por: Qin, Xingping, et al.
Publicado: (2020)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
por: Yu, Kai, et al.
Publicado: (2022)

Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis
por: Zhao, Liang, et al.
Publicado: (2021)

Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway
por: Ye, Yingze, et al.
Publicado: (2019)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms
por: Xiong, Xiaoxing, et al.
Publicado: (2016)

Editorial: The role of immune cells in hepatic ischemia reperfusion
por: Ke, Bibo, et al.
Publicado: (2022)

Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
por: Zhu, Hua, et al.
Publicado: (2023)

APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma
por: Zhu, Hua, et al.
Publicado: (2022)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
por: Qi, Yangzhi, et al.
Publicado: (2020)

Exploration in the Therapeutic and Multi-Target Mechanism of Ketamine on Cerebral Ischemia Based on Network Pharmacology and Molecular Docking
por: Xiong, Li, et al.
Publicado: (2022)

NLRP3 Knockout Protects against Lung Injury Induced by Cerebral Ischemia–Reperfusion
por: Xu, Qingxue, et al.
Publicado: (2022)

Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke
por: Xu, Qingxue, et al.
Publicado: (2021)

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
por: Lafont, Virginie, et al.
Publicado: (2021)

Macrophage Polarization in Cerebral Aneurysm: Perspectives and Potential Targets
por: Shao, Lingmin, et al.
Publicado: (2017)

Editorial: Exploring Immune Variability in Susceptibility to Tuberculosis Infection in Humans
por: Seshadri, Chetan, et al.
Publicado: (2022)

Quantitative and Correlational Analysis of Brain and Spleen Immune Cellular Responses Following Cerebral Ischemia
por: Liu, Qingkun, et al.
Publicado: (2021)

Immunoreactive Cells After Cerebral Ischemia
por: Wang, Yijie, et al.
Publicado: (2019)

Platelets as Modulators of Cerebral Ischemia/Reperfusion Injury
por: Stegner, David, et al.
Publicado: (2019)

Editorial: Immune Surveillance of the HIV Reservoir: Mechanisms, Therapeutic Targeting and New Avenues for HIV Cure
por: Prado, Julia G., et al.
Publicado: (2020)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Editorial: Exploring oncolytic virus-mediated changes in immune microenvironment and immune cells in solid tumors
por: Zhang, Hongwei
Publicado: (2023)

δ-Opioid Receptors, microRNAs, and Neuroinflammation in Cerebral Ischemia/Hypoxia
por: Chen, Yi-Meng, et al.
Publicado: (2020)

Editorial: Immune responses and immune mechanisms triggered by snake and scorpion venoms
por: Pucca, Manuela B., et al.
Publicado: (2022)

Editorial: Update on the Immune Mechanisms Against Respiratory Pathogens
por: Garmendia, Junkal, et al.
Publicado: (2019)

Editorial: Mechanisms of Lung Fibrosis: Is Immunity Back in the Game?
por: Froidure, Antoine, et al.
Publicado: (2022)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Daphnetin Protects against Cerebral Ischemia/Reperfusion Injury in Mice via Inhibition of TLR4/NF-κB Signaling Pathway
por: Liu, Jia, et al.
Publicado: (2016)

Systemic immune responses after ischemic stroke: From the center to the periphery
por: Wu, Fan, et al.
Publicado: (2022)

Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies
por: Xuan, Zixue, et al.
Publicado: (2023)

Editorial: The Molecular Mechanisms of Cyclic AMP in Regulation of Immunity and Tolerance
por: Bodor, Josef
Publicado: (2017)

Editorial: Immune Mechanisms in the Pathologic Response to Particles, Fibers, and Nanomaterials
por: Ma, Qiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ppvl7m7vn4cdhp5agim3ntg0gk